Cue Biopharma【CUE】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

1.08

買値

0.98

売値

1.15

出来高

257,260

1.0203 日の範囲 1.10

0.45 52 週間の範囲 3.20

時価総額

68.418M

前日終値

1.01

始値

1.03

時刻

4746

1.08

最終取引時間

06:00:00

財務取引量

US$ 275,680

VWAP

1.0716

平均取引量 (3 か月)

747,357

発行済株式数

63,350,327

配当利回り

PER

-1.35

1 株当たり利益 (EPS)

-0.8

歳入

5.49M

純利益

-50.73M

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant ... Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.cuebiopharma.com

本社

Wilmington, Delaware, USA

設立

Cue Biopharma Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker CUE. The last closing price for Cue Biopharma was US$1.01. Over the last year, Cue Biopharma shares have traded in a share price range of US$ 0.45 to US$ 3.20.

Cue Biopharma currently has 63,350,327 shares in issue. The market capitalisation of Cue Biopharma is US$63.98 million. Cue Biopharma has a price to earnings ratio (PE ratio) of -1.35.

Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting

Objective response rate (ORR) of 46%, 12-month overall survival (OS) of 91.3% and a median overall survival (mOS) of 21.8 months in first line (1L) HPV+ R/M HNSCC patients treated with CUE-101 and...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.0363	-3.25181402849	1.1163	1.14	0.98	308161	1.017323	CS
4	-0.16	-12.9032258065	1.24	1.27	0.92	305347	1.06087088	CS
12	0.3768	53.5836177474	0.7032	1.9891	0.7032	747357	1.36003601	CS
26	-0.39	-26.5306122449	1.47	1.9891	0.45	604851	1.12993261	CS
52	-1.9	-63.7583892617	2.98	3.2	0.45	444475	1.4254581	CS
156	-11.53	-91.435368755	12.61	12.79	0.45	359255	3.01454172	CS
260	-16.17	-93.7391304348	17.25	35.5	0.45	337946	7.73188889	CS

CUE - Frequently Asked Questions (FAQ)

What is the current Cue Biopharma share price?

The current share price of Cue Biopharma is US$ 1.08

How many Cue Biopharma shares are in issue?

Cue Biopharma has 63,350,327 shares in issue

What is the market cap of Cue Biopharma?

The market capitalisation of Cue Biopharma is USD 63.98M

What is the 1 year trading range for Cue Biopharma share price?

Cue Biopharma has traded in the range of US$ 0.45 to US$ 3.20 during the past year

What is the PE ratio of Cue Biopharma?

The price to earnings ratio of Cue Biopharma is -1.35

What is the cash to sales ratio of Cue Biopharma?

The cash to sales ratio of Cue Biopharma is 12.46

What is the reporting currency for Cue Biopharma?

Cue Biopharma reports financial results in USD

What is the latest annual turnover for Cue Biopharma?

The latest annual turnover of Cue Biopharma is USD 5.49M

What is the latest annual profit for Cue Biopharma?

The latest annual profit of Cue Biopharma is USD -50.73M

What is the registered address of Cue Biopharma?

The registered address for Cue Biopharma is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Cue Biopharma website address?

The website address for Cue Biopharma is www.cuebiopharma.com

Which industry sector does Cue Biopharma operate in?

Cue Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
TOIIWOncology Institute Inc	US$ 0.0197 (109.57%)	42.81k
EVAXEvaxion Biotech AS	US$ 1.58 (86.76%)	6.94M
INTZIntrusion Inc	US$ 0.73 (62.22%)	3.13M
JSPRWJasper Therapeutics Inc	US$ 0.25 (47.06%)	343
RVSNRail Vision Ltd	US$ 1.0904 (40.95%)	5.73M
MITAColiseum Acquisition Corporation	US$ 9.00 (-21.81%)	11.85k
VIRXViracta Therapeutics Inc	US$ 0.1942 (-18.06%)	402.4k
LGCBLinkage Global Inc	US$ 0.39 (-14.66%)	36.31k
BDRXBiodexa Pharmaceuticals PLC	US$ 4.04 (-14.04%)	4.42k
MSGMMotorsport Games Inc	US$ 1.1071 (-11.36%)	527
CRKNCrown Electrokinetics Corporation	US$ 0.1639 (24.45%)	31.95M
OMEXOdyssey Marine Exploration Inc	US$ 0.6299 (31.09%)	9.56M
QSIQuantum Si Inc	US$ 2.66 (23.72%)	6.95M
EVAXEvaxion Biotech AS	US$ 1.58 (86.76%)	6.94M
XTIAXTI Aerospace Inc	US$ 0.04005 (0.13%)	6.58M